Dow Up 0.11% Nasdaq Up 0.50%

Inovio Pharmaceuticals, Inc. (INO)

-NYSE MKT
10.59 Down 0.04(0.38%) Aug 29, 4:00PM EDT
|After Hours : 10.59 0.00 (0.00%) Aug 29, 4:23PM EDT
Prev Close:10.63
Open:10.60
Bid:10.39 x 2400
Ask:10.71 x 500
1y Target Est:21.00
Beta:3.39
Earnings Date:Nov 10 - Nov 14 (Est.)
Day's Range:10.50 - 10.74
52wk Range:6.52 - 15.80
Volume:517,764
Avg Vol (3m):1,866,880
Market Cap:639.61M
P/E (ttm):N/A
EPS (ttm):-1.36
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for INO

Comparison

Symbol% ChgMkt Cap
INODown 0.38%639.61M
AZNUp 2.38%96.00B
PFEUp 0.03%186.36B
SNY 0.00%143.54B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):36.93
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-0.63
Quarterly EPS Est (Sep-14) :-0.14
Mean Recommendation*:1.6
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Inovio Pharmaceuticals, Inc., together with its subsidiaries, discovers, develops, and develops synthetic vaccines and immune therapies focusing on cancers and infectious diseases. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback